These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2713560)
1. The role of alkylating agents in acute and chronic leukemia. Canellos GP Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():46-7. PubMed ID: 2713560 [No Abstract] [Full Text] [Related]
2. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1991; 12():27-42. PubMed ID: 1931447 [No Abstract] [Full Text] [Related]
4. [Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents]. Bernardeschi P; Urbano U Haematologica; 1983; 68(5):684-8. PubMed ID: 6416948 [No Abstract] [Full Text] [Related]
5. [Transfusion and chemotherapeutic treatment of leukemias in the child]. Chieffi A; Cocchi P; Bartolozzi G; Cocchi R Minerva Pediatr; 1966 Jun; 18(19):961-76. PubMed ID: 5925759 [No Abstract] [Full Text] [Related]
6. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Hall AG; Tilby MJ Blood Rev; 1992 Sep; 6(3):163-73. PubMed ID: 1422285 [TBL] [Abstract][Full Text] [Related]
7. Informal discussion: experimental basis for the chemical eradication of leukemia. Frei E Cancer Res; 1967 Dec; 27(12):2656-7. PubMed ID: 6082303 [No Abstract] [Full Text] [Related]
8. Recent advances in the biochemical pharmacology of selected alkylating agents. Wheeler GP Transplant Proc; 1973 Sep; 5(3):1167-70. PubMed ID: 4738047 [No Abstract] [Full Text] [Related]
9. [Chemotherapy of leukemia patients with Myelobromol]. Staeuber PG; Gerhartz H; Liss E Verh Dtsch Ges Inn Med; 1965; 71():733-7. PubMed ID: 5877696 [No Abstract] [Full Text] [Related]
10. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. Skipper HE; Perry S Cancer Res; 1970 Jun; 30(6):1883-97. PubMed ID: 4917694 [No Abstract] [Full Text] [Related]
11. [New ways of the chemotherapy of cancer]. Schmidt CG Krebsarzt; 1969; 24(3):129-49. PubMed ID: 5809854 [No Abstract] [Full Text] [Related]
12. Patterns of resistance to alkylating agents. Osieka R; Grunicke H; Brock N Prog Clin Biol Res; 1986; 223():129-41. PubMed ID: 3809195 [No Abstract] [Full Text] [Related]
13. [Current knowledge of antimitotics and their use in the hematological field]. De Tommasis L; Bilotti G Rass Int Clin Ter; 1966 Sep; 46(18):969-77. PubMed ID: 5991278 [No Abstract] [Full Text] [Related]
14. [Cytostatic therapy of hemoblastosis]. Ehrhart H Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120 [No Abstract] [Full Text] [Related]
16. The many faces of leukemia: the clinical picture. Minkes JG J Am Osteopath Assoc; 1967 Jun; 66(10):1141-51. PubMed ID: 5182824 [No Abstract] [Full Text] [Related]
17. Alkylating agents, nitrosoureas and alkyltriazenes. Connors TA Cancer Chemother Biol Response Modif; 1988; 10():23-32. PubMed ID: 3079385 [No Abstract] [Full Text] [Related]
18. Alkylating agents, nitrosoureas and alkyltriazenes. Connors TA Cancer Chemother Biol Response Modif; 1987; 9():23-35. PubMed ID: 3079405 [No Abstract] [Full Text] [Related]
19. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926 [TBL] [Abstract][Full Text] [Related]
20. [Current status of cytostatic therapy]. Wilmanns W Wien Med Wochenschr; 1974 Nov; 124(48):699-707. PubMed ID: 4611049 [No Abstract] [Full Text] [Related] [Next] [New Search]